To this end, the STAT3-specific antisense oligonucleotide AZD9150 (also known as danvatirsen) was shown to produce a synergistic antitumor effect with immune checkpoint inhibitors (ICIs) in several tumor models [330], including the ICI-resistant tumor models caused by deletion of the tumor suppressor STK11 [331]. Here, STK11 is linked to neoplasm.